This site is intended for health professionals only

At the heart of general practice since 1960

pul jul aug2020 cover 80x101px
Read the latest issue online

Independents' Day

Statin-aspirin heart benefits are confirmed

The benefits of combined use of a statin and aspirin in the secondary prevention of cardiovascular disease have been confirmed by a meta-analysis.

The US analysis, covering five randomised trials of secondary prevention, found add- ing pravastatin (40mg/day) to the use of aspirin alone brought about a 31 per cent relative risk reduction for fatal or non-fatal heart attack (Archives of Internal Medicine, January 12).

Combined aspirin-statin therapy was also 26 per cent more effective at preventing MI than statin alone.

Dr John Pittard, a GP in Staines, Middlesex, who help-ed draw up the CHD national service framework, said UK GPs already made widespread use of combination therapy.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say